Application Note

Denaturing SEC-MS Analysis Of High Molecular Weight Impurities In The GLP-1a Lipopeptides Semaglutide And Tirzepatide

By Stephan M. Koza, Philip Wuthrich, Stephen J. Shiner, and Matthew A. Lauber

GettyImages-2134367155-microscope-lab-gloves-lab-coat-dropper

Understanding high–molecular weight species (HMWS) is essential for ensuring the quality and stability of GLP‑1–based therapeutics like semaglutide and tirzepatide. Explore how denaturing size‑exclusion chromatography coupled with high‑resolution mass spectrometry (dSEC‑HRMS) enables detailed characterization of low‑abundance oligomeric impurities, even when they remain non‑dissociable under harsh conditions. The method provides accurate monomer mass assignments, clear differentiation of dimer and trimer forms, and insight into truncated variants that may arise during storage or degradation. Paired UV detection at 280 nm supports reliable quantitation of both HMWS and monomer concentration. For teams working on peptide stability, formulation, or analytical development, learn more about a blueprint for deeper impurity profiling and analytical considerations needed to interpret complex lipopeptide behavior.

Access the full application note to see the data, spectra, and chromatographic findings in detail.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online